Position Summary
The Executive Director will lead the design and implementation of disease and drug mechanism of action (MoA) studies to advance therapeutics into and through clinical development.
Primary Responsibilities
- Develop translational biology strategies to interrogate disease and drug MoA; implement and drive execution for candidate targets and therapeutics
- Lead nonclinical sciences function; mentor scientists across translational sciences
- Partner across the drug development paradigm to develop and test hypotheses to advance target and candidate molecule evaluation
- Partner with Translational Science colleagues to develop preclinical strategies for indication selection, PK/PD analyses, and mechanistic development for successful IND filing and clinical development
- Synthesize, analyze, and integrate complex biological data to provide clear, actionable insights for drug development decisions
- Identify, evaluate, and leverage cutting-edge technologies to expedite early-stage program development
- Identify and manage CROs; build collaborative relationships with Acadia partners
- Present programs and data for asset team, governance, and senior/executive management review
- Contribute to document generation for preclinical studies and clinical protocols, clinical study reports, statistical analysis plans, research partnerships, regulatory materials (IB, IND, NDA, etc.), and publications
Qualifications
- PhD in life science or related field
- Targeting 15 years of progressively responsible experience in drug development within the pharmaceutical/biotech industry (or equivalent combination of education and experience)
Key Skills (Required/Preferred)
- Strong cross-functional leadership and ability to build collaborative teams
- Hands-on experience across drug discovery, preclinical development, and clinical-stage programs (Phase 1–3), including rare disease
- Demonstrated success leading programs through IND filing; deep expertise in small molecule INDs and regulatory submissions (IND, NDA, BLA)
- Expertise in preclinical (MoA) analysis, indication selection, and supporting clinical development strategies
- Strong understanding of clinical biomarker strategy and development
- Ability to analyze complex, multifactorial datasets; computational literacy (bioinformatics integration is a plus)
- Effective communicator with emotional intelligence; presents complex data to senior leadership
- Ability to make decisions under uncertainty; drive performance through goal-setting and continuous improvement
- Ability to manage multiple priorities in fast-paced environments; domestic/international travel flexibility; neurology experience and modalities (e.g., ASO, mRNA) are a plus
Benefits (as listed)
- Competitive base, bonus, new hire and ongoing equity packages
- Medical, dental, and vision insurance
- Employer-paid life, disability, business travel and EAP coverage
- 401(k) with fully vested company match 1:1 up to 5%
- Employee Stock Purchase Plan with a 2-year purchase price lock-in
- 15+ vacation days; 13–15 paid holidays
- 10 days paid sick time; paid parental leave
- Tuition assistance